Get App Open
In App
Credit Cards
Open App
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 13, 09:25
1923.10 -16.15 (-0.83%)
Volume
AVERAGE VOLUME
5-Day
18,492
10-Day
16,241
30-Day
20,876
942
  • Prev. Close

    1939.25

  • Open Price

    1930.50

  • Bid Price (Qty.)

    1922.90 (2)

  • Offer Price (Qty.)

    1924.40 (14)

NSE Live

Oct 13, 09:25
1924.40 -14.90 (-0.77%)
Volume
AVERAGE VOLUME
5-Day
493,371
10-Day
519,232
30-Day
650,480
27,527
  • Prev. Close

    1939.30

  • Open Price

    1935.00

  • Bid Price (Qty.)

    1923.20 (58)

  • Offer Price (Qty.)

    1924.50 (5)

Financials

Cash Flow of Glenmark Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,399.21 36.50 868.45 1,441.25 1,382.48  
Net CashFlow From Operating Activities -827.60 -265.44 625.39 1,108.65 1,131.21  
Net Cash Used In Investing Activities 2.09 4,560.89 -528.49 -333.28 -675.24  
Net Cash Used From Financing Activities 787.05 -3,906.13 -77.46 -520.49 -441.78  
Foreign Exchange Gains / Losses 55.89 17.68 12.39 17.55 13.62  
Adjustments On Amalgamation Merger Demerger Others 0.00 -191.76 0.67 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 17.44 215.24 32.50 272.43 27.82  
Cash And Cash Equivalents Begin of Year 1,658.27 1,443.03 1,410.53 1,138.10 1,110.28  
Cash And Cash Equivalents End Of Year 1,675.71 1,658.27 1,443.03 1,410.53 1,138.10  
Source : Dion Global Solutions Limited

Results of Glenmark